| DC Field | Value | Language |
|---|
| dc.contributor.author | Martynova, O. V. | - |
| dc.date.accessioned | 2022-04-27T16:45:07Z | - |
| dc.date.available | 2022-04-27T16:45:07Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.citation | Martynova, O.V. Tadalafil as an agent of pharmacological preconditioning in ischemic - reperfusion brain injury / O.V. Martynova // Research result. Pharmacology and clinical pharmacology. - 2017. - Vol. 3, № 3.- P. 20-36. - Doi: 10.18413/2313-8971-2017-3-3-20-36. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46425 | - |
| dc.description.abstract | Ischemic stroke or cerebral infarction is the main pathology among severe forms of vascular lesions of the brain. One of the more effective non-medicamental methods of treatment is pharmacological preconditioning. Pharmacological neuroprotection is one of the treatment areas to reduce the damage in ischemic stroke and other modifications of brain ischemia. Therefore, the development and introduction of new pharmacological agents that can reduce the degree of ischemic-reperfusion injury of the brain, remains one of the major challenges of modern medicine. The most promising to explore, from our point of view, is a PDE-5 inhibitor | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | biology | ru |
| dc.subject | animal physiology | ru |
| dc.subject | pharmacological preconditioning | ru |
| dc.subject | ischemia of the brain | ru |
| dc.subject | tadalafil | ru |
| dc.title | Tadalafil as an agent of pharmacological preconditioning in ischemic - reperfusion brain injury | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 3, № 3
|
